uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Effects of 2-ME on proliferation, apoptosis and PET-tracer uptake in human prostate cancer cell aggregates
Uppsala University, Units outside the University, Ludwig Institute for Cancer Research.
2004 In: Nuclear Medicine and Biology, ISSN 0969-8051, Vol. 7, no Oct 31, 867-874 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2004. Vol. 7, no Oct 31, 867-874 p.
URN: urn:nbn:se:uu:diva-93755OAI: oai:DiVA.org:uu-93755DiVA: diva2:167333
Available from: 2005-11-17 Created: 2005-11-17Bibliographically approved
In thesis
1. 2-ME-Induced Apoptotic Signalling in Prostate Cancer PC3 Cells
Open this publication in new window or tab >>2-ME-Induced Apoptotic Signalling in Prostate Cancer PC3 Cells
2005 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Prostate cancer is common in the Western society and current treatments are often associated with side effects, therefore improved therapeutic strategies are desired. 2-methoxyestradiol (2-ME), an endogenous metabolite of estradiol-17β inhibits tumor growth in vivo as it prevents angiogenesis. 2-ME has also direct cytotoxic effects on tumor cells. In this study, we have investigated the potential use of PET to record effects 2-ME on prostate cancer cell (PC3) aggregates. The anti-proliferative and pro-apoptotic effects of 2-ME on PC3 cell aggregates in vitro were correlated with the uptake of deoxy-D-glucose, FMAU and choline labeled with 18F, 11C or 3H. 2-ME clearly reduced growth of PC3 aggregates and induced apoptosis in a dose-dependent manner. However, the PET tracers failed to record the cytotoxicity of 2-ME on PC3 aggregates.

Further, the signaling events responsible for 2-ME induced prostate cancer cell death were investigated. We found that Smad7, previously implicated in TGF-β-induced responses, is required for 2-ME-induced p38 MAPK activation and subsequent apoptosis in PC-3U cells, as shown by the use of antisense or siRNA techniques and a specific inhibitor of p38 MAPK (SB203580). Interestingly, Smad7 also regulated the expression of the pro-apoptotic Bim protein.

Shb is a Src Homology 2 domain adapter protein with pro-apoptotic effects. PC3 clones overexpressing Shb exhibited increased rates of apoptosis, both in the presence or absence of 2-ME, as they failed to activate survival mechanisms through ERK and Akt in response to 2-ME. Notably, Shb cells displayed increased activity of the pro-apoptotic kinase c-Abl. Pre-treatment with SB203580 or c-Abl (STI-571) inhibitors completely blocked the apoptotic response to 2-ME.

In conclusion, Smad7 and Shb appear to be crucial for 2-ME-induced PC3 cell apoptosis via their activation of p38 MAPK and c-Abl. Future therapies exploring these pathways can be envisaged as treatment of prostate cancer.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2005. 49 p.
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 87
Cell and molecular biology, Prostate cancer, 2-methoxyestradiol, apoptosis, shb, Smad7, Cell- och molekylärbiologi
National Category
Biochemistry and Molecular Biology
urn:nbn:se:uu:diva-6136 (URN)91-554-6401-7 (ISBN)
Public defence
2005-12-09, Room B22, BMC, Husargatan 3, Uppsala, 09:15
Available from: 2005-11-17 Created: 2005-11-17Bibliographically approved

Open Access in DiVA

No full text

By organisation
Ludwig Institute for Cancer Research

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 139 hits
ReferencesLink to record
Permanent link

Direct link